Wellington Management Group LLP Intellia Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 644,763 shares of NTLA stock, worth $7.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

644,763

Previous 781,774 17.53%

Holding current value

$7.77 Million

Previous $17.5 Million 24.27%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $2.7 Million - $3.75 Million	-137,011 Reduced 17.53%	644,763 $13.2 Million
Q2 2024 Aug 13, 2024	SELL	$20.02 - $27.22 $67.7 Million - $92 Million	-3,380,355 Reduced 81.22%	781,774 $17.5 Million
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $99.1 Million - $137 Million	4,162,129 New	4,162,129 $115 Million
Q4 2023 Feb 12, 2024	BUY	$23.16 - $32.34 $56.9 Million - $79.5 Million	2,456,917 New	2,456,917 $74.9 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $1.16 Million - $1.68 Million	36,630 Added 1.4%	2,651,994 $83.9 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $12.1 Million - $16.1 Million	-350,776 Reduced 11.83%	2,615,364 $107 Million
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $32.4 Million - $43.6 Million	971,952 Added 48.74%	2,966,140 $111 Million
Q4 2022 Feb 13, 2023	BUY	$33.21 - $62.69 $47.1 Million - $89 Million	1,418,896 Added 246.64%	1,994,188 $69.6 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $4.56 Million - $6.07 Million	-84,607 Reduced 12.82%	575,292 $32.2 Million
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $4.57 Million - $9.04 Million	-118,613 Reduced 15.24%	659,899 $34.2 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $9.78 Million - $20 Million	167,764 Added 27.47%	778,512 $56.6 Million
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $2.71 Million - $3.73 Million	26,940 Added 4.61%	610,748 $72.2 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $35.5 Million - $47.4 Million	268,167 Added 84.96%	583,808 $78.3 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $19.2 Million - $51.1 Million	315,641 New	315,641 $51.1 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $916M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Intellia Therapeutics, Inc. Transaction History